{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:17816"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:17816","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Amorphous calcium pyrophosphate microspheres as high-surface-area carriers for oral drug delivery","abstract":"Calcium phosphate materials are widely investigated in biomedical science owing to their biocompatibility, degradability, and compositional similarity to the mineral phase of bone and teeth. Among these, calcium pyrophosphate (CaPPi) has received comparatively little attention despite its higher solubility and pH responsiveness, which could be advantageous in drug delivery applications. In this work, amorphous CaPPi microspheres were synthesised under mild aqueous conditions, producing fibrous, spherical assemblies with diameters of 5–15 m and a specific surface area of ∼ 125m\\(^2\\) g\\(^{−1}\\). These structures offer markedly higher surface area than either the initial amorphous precipitate (∼ 65m\\(^2\\) g\\(^{−1}\\)) or the crystalline form (∼ 1.5m\\(^2\\) g\\(^{−1}\\)), suggesting a substantial capacity for macromolecular loading. Particle formation and stability were examined using light microscopy and SEM. Room-temperature drying preserved the fibrous, amorphous structure, whereas drying at 110 ◦C produced crystalline morphologies with loss of porosity. Raman spectroscopy corroborated these findings, with broad phosphate bands consistent with amorphous CaPPi narrowing on crystallisation. These results highlight the importance of controlling processing conditions to preserve the amorphous state, since crystallisation reduces loading potential. The loading capacity of the microspheres was evaluated using three model biopolymers: gelatin, collagen, and carrageenan. Thermogravimetric analysis confirmed substantial uptake of gelatin, whereas collagen loading was negligible despite its chemical similarity, a difference attributed to molecular weight and conformational flexibility. Raman spectra of gelatin-loaded samples confirmed that the CaPPi framework remained amorphous, with only minor contributions from protein bands. Carrageenan displayed distinct behaviour. Its presence during synthesis slowed microsphere formation, most likely through sequestration of Ca\\(^2\\) ions, and SEM revealed surface films consistent with adsorption rather than bulk incorporation. TGA indicated low absolute uptake, and Raman spectra distinguished between incorporation routes: co-precipitation led to partial matrix integration, evidenced by band narrowing, while direct post-synthesis mixing produced spectra dominated by background and fluorescence, consistent with surface association. Together, these findings show that carrageenan perturbs microsphere formation and primarily associates at particle surfaces, whereas gelatin is more readily incorporated into the bulk. Attempts to load microspheres post-manufacture, by immersing dried particles in biopolymer solutions, proved unsuccessful. SEM showed that rehydration consistently triggered crystallisation to blade-like dicalcium pyrophosphate dihydrate, eliminating porosity and preventing meaningful uptake. This confirms that in situ loading during synthesis is the only viable strategy for this system. Drug release was studied using gelatin as a model payload in a simulated gastrointestinal environment. Quantification by BCA assay showed a small degree of premature leakage under gastric conditions (pH 4), followed by increased and sustained release on transition to intestinal pH (pH 7). Release stabilised after an initial adjustment phase and slowed markedly after 60 minutes as the payload was depleted. These results demonstrate partial suppression of gastric release and sustained intestinal release, but not full enteric protection. Analytical attempts to monitor carrageenan release were unsuccessful, reflecting the challenge of quantifying polysaccharide release with existing assay kits. In conclusion, amorphous CaPPi microspheres provide a promising, green-synthesised platform for oral drug delivery. They combine high surface area with delayed release behaviour, but their fragility, susceptibility to crystallisation, and variable interactions with different classes of biomolecules highlight the need for further optimisation. Future work should focus on stabilising the amorphous phase, refining loading strategies for high-molecular-weight and ionic polymers, developing robust analytical methods for polysaccharide release, and applying surface modification to enhance gastric protection. These refinements will be essential to translate the promise of CaPPi microspheres into clinically useful drug delivery systems. This research will focus on at what conditions CaPPi microspheres could be useful drug delivery systems. And how can we control the release of the drug to make sure it has been delivered exactly to the place it should be. Understanding these could help us with improving the drug delivery which can be extremely useful for the patients.","abstract_html":"Calcium phosphate materials are widely investigated in biomedical science owing to their biocompatibility, degradability, and compositional similarity to the mineral phase of bone and teeth. Among these, calcium pyrophosphate (CaPPi) has received comparatively little attention despite its higher solubility and pH responsiveness, which could be advantageous in drug delivery applications. In this work, amorphous CaPPi microspheres were synthesised under mild aqueous conditions, producing fibrous, spherical assemblies with diameters of 5–15 m and a specific surface area of ∼ 125m<span class=\"etd-inline-math\"><sup>2</sup></span> g<span class=\"etd-inline-math\"><sup>−1</sup></span>. These structures offer markedly higher surface area than either the initial amorphous precipitate (∼ 65m<span class=\"etd-inline-math\"><sup>2</sup></span> g<span class=\"etd-inline-math\"><sup>−1</sup></span>) or the crystalline form (∼ 1.5m<span class=\"etd-inline-math\"><sup>2</sup></span> g<span class=\"etd-inline-math\"><sup>−1</sup></span>), suggesting a substantial capacity for macromolecular loading. Particle formation and stability were examined using light microscopy and SEM. Room-temperature drying preserved the fibrous, amorphous structure, whereas drying at 110 ◦C produced crystalline morphologies with loss of porosity. Raman spectroscopy corroborated these findings, with broad phosphate bands consistent with amorphous CaPPi narrowing on crystallisation. These results highlight the importance of controlling processing conditions to preserve the amorphous state, since crystallisation reduces loading potential. The loading capacity of the microspheres was evaluated using three model biopolymers: gelatin, collagen, and carrageenan. Thermogravimetric analysis confirmed substantial uptake of gelatin, whereas collagen loading was negligible despite its chemical similarity, a difference attributed to molecular weight and conformational flexibility. Raman spectra of gelatin-loaded samples confirmed that the CaPPi framework remained amorphous, with only minor contributions from protein bands. Carrageenan displayed distinct behaviour. Its presence during synthesis slowed microsphere formation, most likely through sequestration of Ca<span class=\"etd-inline-math\"><sup>2</sup></span> ions, and SEM revealed surface films consistent with adsorption rather than bulk incorporation. TGA indicated low absolute uptake, and Raman spectra distinguished between incorporation routes: co-precipitation led to partial matrix integration, evidenced by band narrowing, while direct post-synthesis mixing produced spectra dominated by background and fluorescence, consistent with surface association. Together, these findings show that carrageenan perturbs microsphere formation and primarily associates at particle surfaces, whereas gelatin is more readily incorporated into the bulk. Attempts to load microspheres post-manufacture, by immersing dried particles in biopolymer solutions, proved unsuccessful. SEM showed that rehydration consistently triggered crystallisation to blade-like dicalcium pyrophosphate dihydrate, eliminating porosity and preventing meaningful uptake. This confirms that in situ loading during synthesis is the only viable strategy for this system. Drug release was studied using gelatin as a model payload in a simulated gastrointestinal environment. Quantification by BCA assay showed a small degree of premature leakage under gastric conditions (pH 4), followed by increased and sustained release on transition to intestinal pH (pH 7). Release stabilised after an initial adjustment phase and slowed markedly after 60 minutes as the payload was depleted. These results demonstrate partial suppression of gastric release and sustained intestinal release, but not full enteric protection. Analytical attempts to monitor carrageenan release were unsuccessful, reflecting the challenge of quantifying polysaccharide release with existing assay kits. In conclusion, amorphous CaPPi microspheres provide a promising, green-synthesised platform for oral drug delivery. They combine high surface area with delayed release behaviour, but their fragility, susceptibility to crystallisation, and variable interactions with different classes of biomolecules highlight the need for further optimisation. Future work should focus on stabilising the amorphous phase, refining loading strategies for high-molecular-weight and ionic polymers, developing robust analytical methods for polysaccharide release, and applying surface modification to enhance gastric protection. These refinements will be essential to translate the promise of CaPPi microspheres into clinically useful drug delivery systems. This research will focus on at what conditions CaPPi microspheres could be useful drug delivery systems. And how can we control the release of the drug to make sure it has been delivered exactly to the place it should be. Understanding these could help us with improving the drug delivery which can be extremely useful for the patients.","abstract_has_math":true,"creators":["Su, Yen Wei"],"institution":"University of Birmingham","degree_name":"m_sc","degree_level":"m_sc","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026-07","date_published":"2026-07","updated_at":"2026-11-19T09:33:16Z","subjects":["TP Chemical technology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/17816/1/Su2026MScbyRes.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A17816","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Su, Yen Wei"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2026-07"]},{"key":"dc:date.issued","label":"Date","values":["2026-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Engineering & Physical Sciences","School of Chemical Engineering"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/17816/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["m_sc"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["m_sc"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["TP Chemical technology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/17816/1/Su2026MScbyRes.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Calcium phosphate materials are widely investigated in biomedical science owing to their biocompatibility, degradability, and compositional similarity to the mineral phase of bone and teeth. Among these, calcium pyrophosphate (CaPPi) has received comparatively little attention despite its higher solubility and pH responsiveness, which could be advantageous in drug delivery applications. In this work, amorphous CaPPi microspheres were synthesised under mild aqueous conditions, producing fibrous, spherical assemblies with diameters of 5–15 m and a specific surface area of ∼ 125m\\(^2\\) g\\(^{−1}\\). These structures offer markedly higher surface area than either the initial amorphous precipitate (∼ 65m\\(^2\\) g\\(^{−1}\\)) or the crystalline form (∼ 1.5m\\(^2\\) g\\(^{−1}\\)), suggesting a substantial capacity for macromolecular loading. Particle formation and stability were examined using light microscopy and SEM. Room-temperature drying preserved the fibrous, amorphous structure, whereas drying at 110 ◦C produced crystalline morphologies with loss of porosity. Raman spectroscopy corroborated these findings, with broad phosphate bands consistent with amorphous CaPPi narrowing on crystallisation. These results highlight the importance of controlling processing conditions to preserve the amorphous state, since crystallisation reduces loading potential. The loading capacity of the microspheres was evaluated using three model biopolymers: gelatin, collagen, and carrageenan. Thermogravimetric analysis confirmed substantial uptake of gelatin, whereas collagen loading was negligible despite its chemical similarity, a difference attributed to molecular weight and conformational flexibility. Raman spectra of gelatin-loaded samples confirmed that the CaPPi framework remained amorphous, with only minor contributions from protein bands. Carrageenan displayed distinct behaviour. Its presence during synthesis slowed microsphere formation, most likely through sequestration of Ca\\(^2\\) ions, and SEM revealed surface films consistent with adsorption rather than bulk incorporation. TGA indicated low absolute uptake, and Raman spectra distinguished between incorporation routes: co-precipitation led to partial matrix integration, evidenced by band narrowing, while direct post-synthesis mixing produced spectra dominated by background and fluorescence, consistent with surface association. Together, these findings show that carrageenan perturbs microsphere formation and primarily associates at particle surfaces, whereas gelatin is more readily incorporated into the bulk. Attempts to load microspheres post-manufacture, by immersing dried particles in biopolymer solutions, proved unsuccessful. SEM showed that rehydration consistently triggered crystallisation to blade-like dicalcium pyrophosphate dihydrate, eliminating porosity and preventing meaningful uptake. This confirms that in situ loading during synthesis is the only viable strategy for this system. Drug release was studied using gelatin as a model payload in a simulated gastrointestinal environment. Quantification by BCA assay showed a small degree of premature leakage under gastric conditions (pH 4), followed by increased and sustained release on transition to intestinal pH (pH 7). Release stabilised after an initial adjustment phase and slowed markedly after 60 minutes as the payload was depleted. These results demonstrate partial suppression of gastric release and sustained intestinal release, but not full enteric protection. Analytical attempts to monitor carrageenan release were unsuccessful, reflecting the challenge of quantifying polysaccharide release with existing assay kits. In conclusion, amorphous CaPPi microspheres provide a promising, green-synthesised platform for oral drug delivery. They combine high surface area with delayed release behaviour, but their fragility, susceptibility to crystallisation, and variable interactions with different classes of biomolecules highlight the need for further optimisation. Future work should focus on stabilising the amorphous phase, refining loading strategies for high-molecular-weight and ionic polymers, developing robust analytical methods for polysaccharide release, and applying surface modification to enhance gastric protection. These refinements will be essential to translate the promise of CaPPi microspheres into clinically useful drug delivery systems. This research will focus on at what conditions CaPPi microspheres could be useful drug delivery systems. And how can we control the release of the drug to make sure it has been delivered exactly to the place it should be. Understanding these could help us with improving the drug delivery which can be extremely useful for the patients."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Amorphous calcium pyrophosphate microspheres as high-surface-area carriers for oral drug delivery"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Su, Yen Wei"],"dc:date":["2026-07"],"dc:date.issued":["2026-07"],"dc:description.abstract":["Calcium phosphate materials are widely investigated in biomedical science owing to their biocompatibility, degradability, and compositional similarity to the mineral phase of bone and teeth. Among these, calcium pyrophosphate (CaPPi) has received comparatively little attention despite its higher solubility and pH responsiveness, which could be advantageous in drug delivery applications. In this work, amorphous CaPPi microspheres were synthesised under mild aqueous conditions, producing fibrous, spherical assemblies with diameters of 5–15 m and a specific surface area of ∼ 125m\\(^2\\) g\\(^{−1}\\). These structures offer markedly higher surface area than either the initial amorphous precipitate (∼ 65m\\(^2\\) g\\(^{−1}\\)) or the crystalline form (∼ 1.5m\\(^2\\) g\\(^{−1}\\)), suggesting a substantial capacity for macromolecular loading. Particle formation and stability were examined using light microscopy and SEM. Room-temperature drying preserved the fibrous, amorphous structure, whereas drying at 110 ◦C produced crystalline morphologies with loss of porosity. Raman spectroscopy corroborated these findings, with broad phosphate bands consistent with amorphous CaPPi narrowing on crystallisation. These results highlight the importance of controlling processing conditions to preserve the amorphous state, since crystallisation reduces loading potential. The loading capacity of the microspheres was evaluated using three model biopolymers: gelatin, collagen, and carrageenan. Thermogravimetric analysis confirmed substantial uptake of gelatin, whereas collagen loading was negligible despite its chemical similarity, a difference attributed to molecular weight and conformational flexibility. Raman spectra of gelatin-loaded samples confirmed that the CaPPi framework remained amorphous, with only minor contributions from protein bands. Carrageenan displayed distinct behaviour. Its presence during synthesis slowed microsphere formation, most likely through sequestration of Ca\\(^2\\) ions, and SEM revealed surface films consistent with adsorption rather than bulk incorporation. TGA indicated low absolute uptake, and Raman spectra distinguished between incorporation routes: co-precipitation led to partial matrix integration, evidenced by band narrowing, while direct post-synthesis mixing produced spectra dominated by background and fluorescence, consistent with surface association. Together, these findings show that carrageenan perturbs microsphere formation and primarily associates at particle surfaces, whereas gelatin is more readily incorporated into the bulk. Attempts to load microspheres post-manufacture, by immersing dried particles in biopolymer solutions, proved unsuccessful. SEM showed that rehydration consistently triggered crystallisation to blade-like dicalcium pyrophosphate dihydrate, eliminating porosity and preventing meaningful uptake. This confirms that in situ loading during synthesis is the only viable strategy for this system. Drug release was studied using gelatin as a model payload in a simulated gastrointestinal environment. Quantification by BCA assay showed a small degree of premature leakage under gastric conditions (pH 4), followed by increased and sustained release on transition to intestinal pH (pH 7). Release stabilised after an initial adjustment phase and slowed markedly after 60 minutes as the payload was depleted. These results demonstrate partial suppression of gastric release and sustained intestinal release, but not full enteric protection. Analytical attempts to monitor carrageenan release were unsuccessful, reflecting the challenge of quantifying polysaccharide release with existing assay kits. In conclusion, amorphous CaPPi microspheres provide a promising, green-synthesised platform for oral drug delivery. They combine high surface area with delayed release behaviour, but their fragility, susceptibility to crystallisation, and variable interactions with different classes of biomolecules highlight the need for further optimisation. Future work should focus on stabilising the amorphous phase, refining loading strategies for high-molecular-weight and ionic polymers, developing robust analytical methods for polysaccharide release, and applying surface modification to enhance gastric protection. These refinements will be essential to translate the promise of CaPPi microspheres into clinically useful drug delivery systems. This research will focus on at what conditions CaPPi microspheres could be useful drug delivery systems. And how can we control the release of the drug to make sure it has been delivered exactly to the place it should be. Understanding these could help us with improving the drug delivery which can be extremely useful for the patients."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/17816/1/Su2026MScbyRes.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Engineering & Physical Sciences","School of Chemical Engineering"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/17816/"],"dc:subject":["TP Chemical technology"],"dcterms:accessrights":["public"],"dc:title":["Amorphous calcium pyrophosphate microspheres as high-surface-area carriers for oral drug delivery"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["m_sc"],"dc:type.qualificationname":["m_sc"]},"updated_at":"2026-11-19T09:33:16Z"}